Advertisement
News
Advertisement

NicOx Files for EU Approval of Osteoarthritis Drug

Tue, 12/22/2009 - 6:22am
NEW YORK (AP) — French drugmaker NicOx SA said Tuesday it is seeking approval to market its osteoarthritis drug candidate naproxcinod in the European Union. NicOx filed for approval from the European Medicines Agency. The company asked for U.S. marketing approval in September and said it expects the Food and Drug Administration to complete its review by July 24, 2010. The company's U.S. business is headquartered in Warren, N.J.
Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading